Table 1.
Summary of NA mAbs isolated from humans.
| Reactivity | Ref. | mAb Name | Induced after |
|---|---|---|---|
| Group 1 NA | [37] | 1000-3C05, 1000-2E06, 1000-3B04, 1000-3B06, EM-2E01, 1000-1D05, 1000-1E02, 1000-1H01, 294-G-1F01, 294-A-1C02, 295-G-2F04, 300-G-2A04, 300-G-2F04, 294-A-1C06 | H1N1 infection |
| [80] | AG7C, AF9C | Seasonal trivalent inactivated vaccine | |
| Group 2 NA | [37] | 229-1D05, 235-1C02, 235-1E06, 294-1A02, 228-1B03, 228-3F04, 2291B05, 229-1F06, 229-1G03, 229-2B04, 229-2C06, 229-2E02 | H3N2 infection |
| [70,81,82] | NA-97 | A/British Columbia/1/2015 (H7N9) natural infection | |
| [70,81,82] | NA-22, NA-45, NA-63, NA-73, NA-80 | A/Shanghai/2/2013 (H7N9) monovalent inactivated influenza vaccine | |
| Influenza B NA | [83] | NA-1A03, NA-1G05, NA-2D10, NA-2E01, NA-2H09, NA-3C01 | Influenza B infection |
| [84] | 1086C12, 1092D4, 1092E10, 1122C7 | Quadrivalent inactivated influenza vaccine | |
| Pan NA | 1G01, 1E01, 1G04 | H3N2 infection |